Heterogeneous, Longitudinally Stable Molecular Signatures in Response to Interferon-β

Autor: Swathi Chakraborthy, Anupama Josyula, Jennifer Shrock, Yaomin Xu, Richard M. Ransohoff, Jar Chi Lee, M.R. Sandhya Rani, Joerg Schlaak, Richard A. Rudick, Nie Ja

Publikováno v: Annals of the New York Academy of Sciences. 1182:58-68

Interferons (IFNs) are widely used in therapy for viral, neoplastic, and inflammatory disorders, but clinical response varies among patients. The biological basis for variable clinical response is not known. We determined the primary molecular respon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7d731861fc8e024c5ac9ea768c66b51
https://doi.org/10.1111/j.1749-6632.2009.05068.x

Front & Back Matter

Autor: Yuemei Dong, Sandra Jansen, Thomas Pufe, Jose Luis Ramirez, Peter Aaby, Simone C. Tauber, Cornelis van 't Veer, Frank Preijers, Gee W. Lau, Jude M. Taylor, Johanneke Kleinnijenhuis, Jessica Quintin, Tracy Maddocks, Leo A. B. Joosten, Pavel Hyršl, Emma J. Grant, Zhiyong Ma, Pavel Dobeš, Magdiel Pérez-Cruz, Lucie Kucerova, Rommel Max Tan, Mihai G. Netea, Mengji Lu, Jaring S. van der Zee, Cristina Costa, Zhi Wang, Yonghua Hao, Alvaro Molina-Cruz, Janneth Rodrigues, Zhizhou Kuang, Joke van Loenhout, Florry E. van den Boogaard, Jean Gosselin, Mercedes Monteleone, Amanda Skora, Jason D. McArthur, Marie Ranson, Victor Nizet, Katherine Kedzierska, Jos W. M. van der Meer, George Dimopoulos, Druckerei Stückle, James A. Tsatsaronis, Diane Ly, Alexandre Brunet, Rongjuan Pei, Badrul Arefin, Thekla Kemper, Reinout van Crevel, Carolina Barillas-Mury, Dimitri A. Diavatopoulos, Ulrich Theopold, Luiz Carlos Alves, Fábio André Brayner, Satz Mengensatzproduktion, Alex F. de Vos, Stan de Kleijn, Lea-Jessica Albrecht, Manon Le Bel, Mark J. Walker, Aldert Zomer, Michal Zurovec, Jonas Höss, Arie J. Hoogendijk, Patrick C. Reading, Xiaoyong Zhang, Cortny A. Donald, Nicholas P. West, Robert Markus, Xinwen Chen, Bo Qin, Regina de Beer, Peter W. M. Hermans, Eugenia Kress, Lars-Ove Brandenburg, Hynek Strnad, Martina L. Sanderson-Smith, Lindsey S. Garver, Joerg Schlaak, Marloes Vissers, Tom van der Poll, Christine Stabell Benn, Martin Trippler, Kirsty R. Short, Gerben Ferwerda, Oliver Soehnlein, Wandi Zhu, Joris J. T. H. Roelofs, Ramnik J. Xavier, Cor Jacobs, Rafael Mañez, Julika Merres, J. Daan de Boer, Jack Yang, April M. Clayton

Publikováno v: Journal of Innate Immunity. 5:X-X

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6480e4fea5bb4a218be7a22bf41f188b
https://doi.org/10.1159/000354406

Core promoter mutant HBV non-responding to adefovir after viral breakthrough on lamivudine: rapid virologic response to tenofovir plus lamivudine in a cirrhotic patient

Autor: Katsounas, A., Jochum, C., Canbay, A., Joerg Schlaak, Gerlich, W. H., Gerken, G.

Publikováno v: Europe PubMed Central
Scopus-Elsevier

In chronic hepatitis B patients undergoing therapy with LAM or ADV, viral breakthrough is possible due to the emergence of drug resistance. LAM resistant HBV strains are susceptible to ADV, while ADV resistant mutants remain sensitive to LAM.A male p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1febd3c1b3c2a222234295709c29cadc
http://europepmc.org/abstract/med/19008175